Wyoming Department of Health reports first Measles Case in Natrona County
On Jul. 1, 2025, the Wyoming Department of Health (WDH) has confirmed a case of measles in an…
AbbVie to Acquire Capstan Therapeutics for $2.1 billion
On Jun. 30, 2025, AbbVie and Capstan Therapeutics announced a definitive agreement under which AbbVie will acquire Capstan,…
Precision gene editing medicine makes history, and it’s just getting started
On Jun. 30, 2025, as in something out of science fiction, a team of researchers reached into the…
Parkinson’s drug effective in treating persistent depression
On Jun. 30, 2025, a University of Oxford led study reported that a drug used for Parkinson’s disease…
A rare form of leprosy existed in the Americas for thousands of years
On Jun. 30, 2025, a new study from an international team of researchers led by the Max Planck…
Calgary reintroduces fluoride into drinking water
On Jun. 30, 2025, Fluoride was reintroduced into the drinking water in Alberta’s largest city nearly four years…
Scientists discover network of cells and genes involved in Crohn’s disease complication
On Jun. 30, 2025, the Broad Institute announced that spatial mapping reveals genes contributing to fibrosis, or scarring,…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Vaccine | WHO
WHO Scientific advisory group issues report on origins of COVID-19
On Jun. 27, 2025, the World Health Organization (WHO) Scientific Advisory Group for the Origins of Novel Pathogens…
Researchers take first steps to creating synthetic human genomes
On Jun. 26, 2025, a team of UK-based scientists announced they are developing technology to create the first…
TSU Breaks Ground on New $90 Million Agriculture Facilities
On Jun. 26, 2025, Tennessee State University leaders, dignitaries, and College of Agriculture faculty broke ground on the…
CDC’s Advisory Committee on Immunization Practices Approves RSV and influenza Vaccines
On Jun. 26, 2025, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
New Mexico announces measles outbreak in a county detention facility
On Jun. 26, 2025, the New Mexico Department of Health (NMDOH) announced that five people who are incarcerated…
Google DeepMind Announces AlphaGenome: AI for better understanding the genome
On Jun. 25, 2025, Google Deepmind introduce AlphaGenome, a new artificial intelligence (AI) tool that more comprehensively and…
Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control
On Jun. 25, 2025, Femasys announces Conformité Européene (CE) mark certification under European Union Medical Device Regulation of…
Penn engineers turn toxic fungus into anti-cancer drug
On Jun. 25, 2025, researchers at the University of Pennylvanis’s School of Engineering and Applied Science announced they…
Agriculture | Biotechnology | Clinical Research | Cloning | COVID-19 | Diagnostics | FDA | Genomics | Infectious Disease | Marine Science | Medical Device | NIH | Non-Profit Research | Oncology | Stem Cell | Therapeutics | U.S. Congress | USDA | Vaccine | Veterinary | Women's Health
NIH will reinstate 900 grants in response to court order
On Jun. 25, 2025, the National Institutes of Health (NIH) moved to reinstate about 900 grants that a…
Biotechnology | COVID-19 | HIV | Infectious Disease | Influenza | Measles | Polio | Vaccine
Amid multi-state measles outbreak, Poll Shows 79% of Americans support routine childhood vaccine requirements
On Jun. 25, 2025, in the midst of a multi-state measles outbreak, a poll by Harvard T.H. Chan…
Biotechnology | COVID-19 | HIV | Infectious Disease | Influenza | Measles | NIH | Polio | U.S. Congress | Vaccine | Women's Health
U.S. to stop financial support of global vaccine alliance Gavi
On Jun. 25, 2025, the U.S. will announced it will no longer contribute funding to Gavi, a global…
Oregon’s first measles case of 2025 confirmed in Multnomah County
On Jun. 24, 2025, the Oregon Health Authority and county public health officials announced they are investigating a…
Texas Reports no New Measles cases in Ongoing outbreak
On Jun. 24, 2025, the Texas Department of State Health Services (DSHS) reported a total of 750 cases…
Biotechnology | COVID-19 | Infectious Disease | Measles | Polio | Vaccine | WHO
Millions of children at risk as childhood vaccination coverage stalls globally
On Jun. 24, 2025, the Institute for Health Metrics and Evaluation (IHME) announced results from the Global Burden…
First Case of Measles Identified in North Carolina
On Jun. 24, 2025, the North Carolina Department of Health and Human Services has confirmed a case of…
CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults overweight or obesity in REDEFINE 1, published in NEJM
On Jun. 22, 2025, The New England Journal of Medicine (NEJM) published results from Novo Nordisk’s phase 3…
Biotechnology | Disease | FDA | Medicine | Therapeutics
Dupixent approved in the U.S. as the only targeted medicine to treat patients with bullous pemphigoid
On Jun. 20, 2025, the US Food and Drug Administration (FDA) announced it has approved Dupixent (dupilumab) for…
Vertex Reports Positive Data for Zimislecel in Type 1 Diabetes
On Jun. 20, 2025, Vertex Pharmaceuticals announced publication of updated data from the Phase 1/2 portion of the…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
USDA Announces Plan to Combat New World Screwworm’s Northward Spread
On Jun. 18, 2025, the U.S. Department of Agriculture announced it has launched an $8.5 million sterile New…
Molecular test confirms antimalarial antibody’s efficacy
On Jun. 18, 2025, researchers at the University of Washington (UW) School of Medicine announced that a highly…
Biotechnology | Chemistry | Environmental | EPA | Radiology
Why Eliminating EPA’s Research Arm Endangers Public Health and U.S. Competitiveness
On Jun. 18, 2025, In a new Proceedings of the National Academy of Sciences (PNAS) opinion paper, former…
Biotechnology | CDC | FDA | HIV | Infectious Disease | Medicine | Therapeutics
Yeztugo® (Lenacapavir) Is the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection
On Jun. 18, 2025, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo®…
Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery
On Jun. 18, 2025, SandboxAQ, an artificial intelligence startup spun out of Alphabet’s Google and backed by Nvidia…